Pseudojervine

CAS No. 36069-05-3

Pseudojervine( Jervin-3-glucoside | O-beta-D-Glucopyranosyljervine )

Catalog No. M29248 CAS No. 36069-05-3

Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 142 Get Quote
5MG 250 Get Quote
10MG 410 Get Quote
25MG 662 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pseudojervine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
  • Description
    Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Jervin-3-glucoside | O-beta-D-Glucopyranosyljervine
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    36069-05-3
  • Formula Weight
    587.754
  • Molecular Formula
    C33H49NO8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@H]1[C@@H]2NC[C@@H](C)C[C@H]2O[C@]11CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3C(=O)C2=C1C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NMS-E973

    NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.

  • Benzcyclane

    Benzcyclane (Benzcyclan) is an inhibitor of platelet aggregation and also a vasodilator that can be used in a variety of peripheral circulation disorders.

  • Dextran

    Dextran (Dextran 40) has an inhibitory effect on platelet aggregation and coagulation factors, and is used as an agent for increasing plasma volume.